Hawkins HWKN · NASDAQ
$131.42 -0.18% (-$0.24)
Summary
74 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 18% a year over the last 3 years.
- Out of every 100 USD of revenue, 7.3 USD is left as net profit.
- It earns 9.5 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- It missed profit estimates 6 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 34.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 8.0% a year. Earnings per share grew by 18% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 78 USD
- Sales and administration 12 USD
- Taxes and other 3.0 USD
- Net profit 7.3 USD
Net profit, industry median (Chemicals - Specialty) 5.9 USD
Out of every 100 USD of revenue, 7.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.59%
- Paid out of profit
- 20%
- Raised in a row
- 3 years
You receive $0.77 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $142 is 8.1% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Nutrition 32%
- Food 23%
- Bulk 22%
- Agricultural 12%
- Pharmaceutical 6.5%
- Other 3.2%
By region
The company reports no revenue by region.
Nutrition brings in 32% of revenue.
Segments in detail